Synergia Medical is pioneering optoelectronics for neural stimulation therapies by developing an innovative, powerful and versatile neural stimulation technological platform.
By doing so, Synergia Medical will improve patients’ quality of life and pave the way to new personalized therapies.
Full range of applications
Synergia Medical’s technology could benefit numerous neurological diseases such as chronic pain, Parkinson’s disease, drug-resistant epilepsy, sleep apnoea and depression.
Synergia Medical’s current IP portfolio includes non-metallic encapsulation of neurostimulators, fast-charging wireless system, a custom optical lead, miniaturized photovoltaic cells and an enhanced electrode.
News and Events
Sophie Baratte becomes Chair of the Board of Synergia Medical
Synergia Medical proudly announces the appointment of Mrs. Sophie Baratte as Chair of the Board.
First US patent
Synergia Medical just obtained its first patent in the United States for its optical energy neurostimulator.
Yves Jongen becomes Chairman of the Board ad interim
Yves Jongen, currently board member of Synergia Medical, succeeds Reinhard Krickl and becomes Chairman ad interim.